Impact of SARS-CoV-2 infection on longitudinal vaccine immune responses

Sebastian Havervall, Ulrika Marking, Nina Greilert-Norin, Max Gordon, Henry Ng, Wanda Christ, Kim Blom, Mia Phillipson, Peter Nilsson, Sophia Hober, Jonas Klingström, Sara Mangsbo, Mikael Åberg, Charlotte Thålin
doi: https://doi.org/10.1101/2021.10.16.21264948

Article usage

Article usage: October 2021 to November 2024

AbstractFullPdf
Oct 2021294357683
Nov 202199324301
Dec 202131727127
Jan 20222581176
Feb 2022359946
Mar 20221241333
Apr 2022111128
May 202291431
Jun 202268122
Jul 20226138
Aug 20226048
Sep 202293420
Oct 202277611
Nov 20225206
Dec 20225118
Jan 20233809
Feb 20234555
Mar 20233004
Apr 202344417
May 202332111
Jun 20232263
Jul 20232838
Aug 2023471212
Sep 202334510
Oct 20233801
Nov 202339123
Dec 20232215
Jan 20242041
Feb 20243147
Mar 202422610
Apr 2024271011
May 20242746
Jun 2024321214
Jul 202430311
Aug 2024501118
Sep 20243344
Oct 202432108
Nov 202415112
Back to top
Posted October 19, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Impact of SARS-CoV-2 infection on longitudinal vaccine immune responses
Sebastian Havervall, Ulrika Marking, Nina Greilert-Norin, Max Gordon, Henry Ng, Wanda Christ, Kim Blom, Mia Phillipson, Peter Nilsson, Sophia Hober, Jonas Klingström, Sara Mangsbo, Mikael Åberg, Charlotte Thålin
medRxiv 2021.10.16.21264948; doi: https://doi.org/10.1101/2021.10.16.21264948
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area